Malin Corporation plc (MLC.IR)

EUR 8.7

(0.0%)

Market Cap (In EUR)

164.33 Million

Revenue (In EUR)

-

Net Income (In EUR)

-

Avg. Volume

2485.00

Currency
EUR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
4.22-8.9
PE
-
EPS
-
Beta Value
0.895
ISIN
-
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. William F. Daniel
Employee Count
-
Website
https://malinplc.com
Ipo Date
2014-03-25
Details
Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an unmet need in women's health and onychomycosis or fungal nail infection. The company also provides drugs for protein misfolding diseases; and platform to distinguish disease-driving bacteria from the intestinal microbiota, as well as UV-light disinfection technology solutions. In addition, it provides company secretarial services. Malin Corporation plc was incorporated in 2014 and is headquartered in Dublin, Ireland.